4-甲基芦竹碱 | 164119-81-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 4-甲基芦竹碱
• 英文名称: N,N-dimethyl-1-(4-methyl-1H-indol-3-yl)methanamine
• 英文别名: 3-dimethylaminomethyl-4-methylindole；dimethyl-(4-methyl-indol-3-ylmethyl)-amine；Dimethyl-(4-methyl-indol-3-ylmethyl)-amin；dimethyl-(4-methyl-1H-indol-3-ylmethyl)amine
• CAS: 164119-81-7
• 化学式: C₁₂H₁₆N₂
• mdl: MFCD01074514
• 分子量: 188.272
• InChiKey: GEZUIRKWLKMHQN-UHFFFAOYSA-N

物化性质

• 沸点：
  310.7±27.0 °C(Predicted)
• 密度：
  1.077±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  19
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  4-甲基芦竹碱 在 四氢呋喃 、 溶剂黄146 、 硫酸二甲酯 作用下， 生成 4-甲基吲哚-3-乙腈
  参考文献：
  名称：

  Gaddum et al., 1955, vol. 40, p. 49,53

  摘要：

  DOI：
• 作为产物：
  描述：

  N,N-dimethyl-1-[4-methyl-1-tri(propan-2-yl)silylindol-3-yl]methanamine 在 四丁基氟化铵 作用下， 以 四氢呋喃 为溶剂， 以95%的产率得到4-甲基芦竹碱
  参考文献：
  名称：

  通过有机金属反应与对映选择性酶促转化的组合合成对映体纯的4-烷基取代的色氨酸衍生物

  摘要：

  描述了对映体纯的4-取代的色氨酸12的合成。关键步骤是：i）通过N-TIPS保护的氨基胺的区域选择性锂化将烷基取代基引入吲哚的4-位；以及ii）青霉素G酰基转移酶对4-取代的色氨酸的苯基乙酰胺进行对映选择性皂化。

  DOI：

  10.1016/0040-4039(95)00001-s

文献信息

• [EN] HYDRAZONE COMPOUNDS AND THEIR USE<br/>[FR] COMPOSÉS D'HYDRAZONE ET LEUR UTILISATION
  申请人：STEIN PHILIP

  公开号：WO2010132615A1

  公开（公告）日：2010-11-18

  The present invention relates to hydrazone compounds of Formula I: (I) and pharmaceutically acceptable salts and stereoisomers thereof, wherein R1, R2, R3, R4, L1, and L2 are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I as inhibitors of TRPM5 protein.

  本发明涉及式I的腙化合物：(I)及其药用可接受的盐和立体异构体，其中R1、R2、R3、R4、L1和L2的定义如规范中所述。该发明还涉及将式I的化合物用作TRPM5蛋白的抑制剂。
• Discovery of a lead series of potent benzodiazepine 5-HT2C receptor agonists with high selectivity in functional and binding assays
  作者：Albert Ren、Xiuwen Zhu、Konrad Feichtinger、Juerg Lehman、Michelle Kasem、Thomas O. Schrader、Amy Wong、Huong Dang、Minh Le、John Frazer、David J. Unett、Andrew J. Grottick、Kevin T. Whelan、Michael E. Morgan、Carleton R. Sage、Graeme Semple

  DOI：10.1016/j.bmcl.2019.126929

  日期：2020.3

  potential new 5-HT2 receptor scaffolds based on a simplification of the clinically studied, 5-HT2CR agonist vabicaserin, were designed. An in vivo feeding assay early in our screening process played an instrumental part in the lead identification process, leading us to focus on a 6,5,7-tricyclic scaffold. A subsequent early SAR investigation provided potent agonists of the 5-HT2C receptor that were highly

  根据简化的临床研究，设计了一系列潜在的新型5-HT2受体支架5-HT2CR激动剂vabicaserin。在筛选过程的早期，体内喂养试验在铅识别过程中发挥了重要作用，使我们专注于6,5,7-三环支架。随后的早期SAR研究提供了有效的5-HT2C受体激动剂，该激动剂在功能和结合测定中具有高度选择性，具有良好的大鼠PK特性，并显着降低了大鼠的急性食物摄入量。
• [EN] 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE<br/>[FR] AGONISTES DU RÉCEPTEUR 5-HT2C ET COMPOSITIONS ET PROCÉDÉS D'UTILISATION
  申请人：ARENA PHARM INC

  公开号：WO2015066344A1

  公开（公告）日：2015-05-07

  Provided are 5-HT2C receptor agonists. Also provided are methods for weight management, inducing satiety, and decreasing food intake, and for preventing and treating obesity, antipsychotic-induced weight gain, type 2 diabetes, Prader-Willi syndrome, tobacco/nicotine dependence, drug addiction, alcohol addiction, pathological gambling, reward deficiency syndrome, and sex addiction), obsessive-compulsive spectrum disorders and impulse control disorders (including nail-biting and onychophagia), sleep disorders (including insomnia, fragmented sleep architecture, and disturbances of slow-wave sleep), urinary incontinence, psychiatric disorders (including schizophrenia, anorexia nervosa, and bulimia nervosa), Alzheimer disease, sexual dysfunction, erectile dysfunction, epilepsy, movement disorders (including parkinsonism and antipsychotic-induced movement disorder), hypertension, dyslipidemia, nonalcoholic fatty liver disease, obesity-related renal disease, and sleep apnea. Also provided are compositions comprising a selective 5-HT2C receptor agonist, optionally in combination with a supplemental agent, and methods for reducing the frequency of smoking tobacco in an individual attempting to reduce frequency of smoking tobacco; aiding in the cessation or lessening of use of a tobacco product in an individual attempting to cease or lessen use of a tobacco product; aiding in smoking cessation and preventing associated weight gain; controlling weight gain associated with smoking cessation by an individual attempting to cease smoking tobacco; reducing weight gain associated with smoking cessation by an individual attempting to cease smoking tobacco; treating nicotine dependency, addiction and/or withdrawal in an individual attempting to treat nicotine dependency, addiction and/or withdrawal; or reducing the likelihood of relapse use of nicotine by an individual attempting to cease nicotine use comprising administering a selective 5-HT2C receptor agonist, optionally in combination with a supplemental agent.

  提供了5-HT2C受体激动剂。还提供了用于体重管理、诱导饱腹感、减少食物摄入量、预防和治疗肥胖、抗精神病药物引起的体重增加、2型糖尿病、普拉德-威利综合征、烟草/尼古丁依赖、药物成瘾、酒精成瘾、病态赌博、奖赏缺乏综合征和性成瘾）、强迫症谱系障碍和冲动控制障碍（包括咬指甲和咬甲）、睡眠障碍（包括失眠、睡眠结构碎裂和慢波睡眠紊乱）、尿失禁、精神障碍（包括精神分裂症、厌食症和暴食症）、阿尔茨海默病、性功能障碍、勃起功能障碍、癫痫、运动障碍（包括帕金森病和抗精神病药物引起的运动障碍）、高血压、血脂异常、非酒精性脂肪肝病、肥胖相关肾脏疾病和睡眠呼吸暂停。还提供了包含选择性5-HT2C受体激动剂的组合物，可选地与辅助剂结合，以及用于减少个体尝试减少吸烟频率的吸烟频率；帮助个体戒除或减少使用烟草制品的个体戒除或减少使用烟草制品；帮助戒烟并预防相关体重增加；通过个体尝试戒烟来控制与戒烟相关的体重增加；通过个体尝试戒烟来减少与戒烟相关的体重增加；治疗尼古丁依赖、成瘾和/或戒断的个体尝试治疗尼古丁依赖、成瘾和/或戒断；或减少个体尝试戒除尼古丁使用的复发可能性，包括给予选择性5-HT2C受体激动剂，可选地与辅助剂结合。
• Synthesis and Biological Activities of 4-Trifluoromethylindole-3-acetic Acid: A New Fluorinated Indole Auxin
  作者：Masato KATAYAMA、Yuko MASUI、Eiji KAGEYAMA、Youichi KAWABATA、Kozo KANAYAMA

  DOI：10.1271/bbb.80138

  日期：2008.8.23

  biological activities of these compounds were compared by three bioassays with those of indole-3-acetic acid and 4-chloroindole-3-acetic acid (4-Cl-IAA), which, like 4-CF(3)-IAA and 4-CH(3)-IAA, has a substituent at the 4-position of the indole nucleus. 4-CF(3)-IAA showed strong root formation-promoting activity with black gram cuttings which was 1.5 times higher than that of 4-(3-indole)butyric acid at 1x10(-4)

  在我们对树木cutting插根形成新促进剂的研究中，通过4-三氟甲基吲哚和4-三氟乙酸合成了一种新的氟化生长素4-三氟甲基吲哚-3-乙酸（4-CF（3）-IAA）。三氟甲基吲哚-3-乙腈，以2-甲基-3-硝基苯并三氟为原料。作为比较生物活性的对照化合物，还以2,3-二甲基硝基苯为原料合成了4-甲基吲哚-3-乙酸（4-CH（3）-IAA）。通过三种生物测定法将这些化合物的生物活性与吲哚-3-乙酸和4-氯吲哚-3-乙酸（4-Cl-IAA）进行了比较，后者与4-CF（3）-IAA和4 -CH（3）-IAA在吲哚核的4位上具有取代基。4-CF（3）-IAA在1x10（-4）M时显示出很强的根形成促进活性，带有黑克屑，比4-（3-吲哚）丁酸高1.5倍.4-CH（3） -IAA尽管对白菜的下胚轴生长有强烈的抑制作用，而在黑克中却促进下胚轴膨胀和侧根形成，但它仅能弱地促进根形成。另一方面，在这两种生物测
• PESTICIDAL COMPOSITION COMPRISING INDOLE DERIVATES
  申请人：Bednarek Pawel

  公开号：US20090028796A1

  公开（公告）日：2009-01-29

  The present invention is directed to pesticidal compositions comprising indole derivatives. These indole derivatives are especially active against phytopathogenic fungi. Furthermore, the invention relates to the use of indole derivatives for the production of pesticides and the use of the compositions according to the invention as pesticides. The present invention is also directed to a process for producing a pesticidal composition and to pesticidal compositions prepared by this process. In addition, the invention relates to a process for preventing or combating pests and to a process for protecting plants against pests, especially against phytopathogenic fungi. Further, the invention is directed to plants or seeds as well as objects or materials which have been protected against pests by treatment with a composition according to the invention. Further, the invention is directed to a method for identifying a substance having pesticidal activity. Further, the invention is directed to a method of identifying the mode of action of and/or of providing binding proteins for a pesticidal compound of the present invention. Finally, the invention is directed to a method for diagnosing pest infection of a plant and to the use of a pesticidal compound of the present invention as diagnostic markers.

  本发明涉及包含吲哚衍生物的杀虫组合物。这些吲哚衍生物特别对植物病原真菌具有活性。此外，本发明涉及使用吲哚衍生物制备杀虫剂以及使用本发明中的组合物作为杀虫剂。本发明还涉及制备杀虫组合物的过程以及通过该过程制备的杀虫组合物。此外，本发明还涉及预防或对抗害虫的过程以及保护植物免受害虫，特别是植物病原真菌的过程。此外，本发明还涉及经过本发明中的组合物处理后受到保护的植物或种子以及物体或材料。本发明还涉及识别具有杀虫活性的物质的方法。此外，本发明还涉及识别本发明中杀虫化合物的作用方式和/或提供结合蛋白的方法。最后，本发明涉及诊断植物害虫感染的方法以及使用本发明中的杀虫化合物作为诊断标记的方法。